Rankings
▼
Calendar
IVVD (Invivyd, Inc.) Stock Financials & Earnings | Market Cap Arena
IVVD
Invivyd, Inc.
Mkt Cap
$257M
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$53M
Net Income (TTM)
-$52M
EPS (TTM)
-$0.38
Free Cash Flow (TTM)
-$58M
Gross Margin
93.0%
Op. Margin
-104.0%
Net Margin
-98.2%
FCF Margin
-109.1%
P/S Ratio (TTM)
4.8x
P/E Ratio (TTM)
—
YoY Rev Growth
+110.5%
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Next: Q1 2026 · Mar 19
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$0
$0
-$39M
Q2 23
$0
$0
-$54M
Q3 23
$0
$0
-$43M
Q4 23
$0
$0
-$77M
Q1 24
$0
$0
-$46M
Q2 24
$2M
$2M
-$49M
Q3 24
$9M
$8M
-$62M
Q4 24
$14M
$13M
-$19M
Q1 25
$11M
$10M
-$17M
Q2 25
$12M
$11M
-$15M
Q3 25
$13M
$12M
-$11M
Q4 25
$17M
$16M
-$13M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
—
—
Q2 23
—
—
Q3 23
—
—
Q4 23
—
—
Q1 24
—
—
Q2 24
113.7x
—
Q3 24
22.3x
—
Q4 24
10.1x
—
Q1 25
7.0x
—
Q2 25
5.6x
—
Q3 25
5.1x
—
Q4 25
4.8x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$41M
-$42M
Q2 23
-$37M
-$37M
Q3 23
-$35M
-$35M
Q4 23
-$59M
-$59M
Q1 24
-$50M
-$50M
Q2 24
-$42M
-$42M
Q3 24
-$41M
-$41M
Q4 24
-$38M
-$38M
Q1 25
-$21M
-$21M
Q2 25
-$13M
-$13M
Q3 25
-$8M
-$8M
Q4 25
-$15M
-$15M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$624K
Q2 23
$9K
Q3 23
$0
Q4 23
$0
Q1 24
$140K
Q2 24
$0
Q3 24
$5K
Q4 24
$5K
Q1 25
$144K
Q2 25
$11K
Q3 25
$0
Q4 25
$0
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
—
-61.2%
Q2 23
—
+4.1%
Q3 23
—
-9.0%
Q4 23
—
+59.2%
Q1 24
—
+18.0%
Q2 24
—
-4.4%
Q3 24
—
+66.3%
Q4 24
—
-56.9%
Q1 25
—
-38.8%
Q2 25
+420.6%
-47.9%
Q3 25
+41.2%
-66.3%
Q4 25
+24.5%
-9.9%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$5M
—
Q2 23
$5M
—
Q3 23
$4M
—
Q4 23
$4M
—
Q1 24
$5M
—
Q2 24
$8M
375.0%
Q3 24
$3M
30.8%
Q4 24
$3M
22.1%
Q1 25
$3M
25.0%
Q2 25
$3M
27.0%
Q3 25
$3M
23.4%
Q4 25
$3M
14.9%
marketcaparena.com
OpEx Breakdown
R&D
G&A
SG&A
Quarter
R&D
G&A
SG&A
Q1 23
$27M
$11M
—
Q2 23
$44M
$10M
—
Q3 23
$26M
$13M
—
Q4 23
$62M
$15M
—
Q1 24
$31M
$15M
—
Q2 24
$30M
$21M
—
Q3 24
$58M
$13M
—
Q4 24
$18M
$14M
—
Q1 25
$11M
$17M
—
Q2 25
$10M
$17M
—
Q3 25
$8M
$15M
—
Q4 25
$10M
—
$19M
marketcaparena.com
Revenue Segments
Product
Quarter
Product
Q2 24
$2M
Q3 24
$9M
Q4 24
$14M
Q1 25
$11M
Q2 25
$12M
Q3 25
$13M
Q4 25
$17M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$126M
$207M
$333M
Q2 23
$122M
$176M
$298M
Q3 23
$182M
$83M
$265M
Q4 23
$201M
$0
$201M
Q1 24
$189M
$0
$189M
Q2 24
$148M
$0
$148M
Q3 24
$107M
$0
$107M
Q4 24
$69M
$0
$69M
Q1 25
$48M
$0
$48M
Q2 25
$35M
$0
$35M
Q3 25
$85M
$0
$85M
Q4 25
$227M
$0
$227M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
109M
-0.2%
Q2 23
109M
+0.6%
Q3 23
110M
+0.3%
Q4 23
110M
+0.1%
Q1 24
116M
+5.2%
Q2 24
119M
+3.2%
Q3 24
119M
+0.1%
Q4 24
119M
-0.8%
Q1 25
120M
+1.1%
Q2 25
120M
+0.1%
Q3 25
170M
+41.8%
Q4 25
172M
+1.2%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 20
—
—
FY 21
$0
101
FY 22
$0
100
FY 23
$0
94
FY 24
$256K
99
FY 25
$438K
122
marketcaparena.com